Skip to content
Solvance Pharma

Solvance Pharma

LargePrithvi NairPrithvi Nair · Director, Regulatory Ops KB v1
Open full session

Deal stage

— where this deal is in its journey, first contact to close
ProspectJul 4, 2026 • 6:24 PM
EngagedJul 5, 2026 • 8:02 PM
Qualified
Meeting Booked
Closed Lost

Deal snapshot

Win chance, the value at stake, and how far this deal has come.

Win chance

30%to close

Weighted to $183K

Value at stake

Full value vs. risk-adjusted.

Pipeline progress

2/5stage

Engaged · 17d since touch

Pre-call brief

Solvance Pharma is cooling in Engaged — 17 days since the last touch, $610K at risk. Recommended next move: Re-engage Solvance Pharma.

StageEngaged · 30% win probability.
Value$610K open, $183K weighted.
MomentumCooling — 17 days since the last activity.
Next stepScheduled for Jul 25, 2026.

Recommended: Re-engage Solvance Pharma

A quick read on this deal from your agent — where it stands and the smartest next move — so you're prepared before you call or email. The agent never reaches out on its own.

Deal value

$610K

The full amount if it closes.

Weighted

$183K

30% chance of closing

Owner

Suren DheenSuren Dheen

Who's running this deal — that's you.

Last activity

Jul 5, 2026 • 8:02 PM · 17d quiet

Your most recent logged call, email, or note — 17 days ago.

Next step scheduled: Jul 25, 2026

Agent — next best action for this deal

Solvance Pharma

Re-engage Solvance Pharma

No activity in 17 days on a $610K deal sitting at "Engaged" — it's going cold. Draft a value nudge to bring it back.

Open deal
Solvance Pharma

Follow up with Solvance Pharma

You set a follow-up with Solvance Pharma for 7/25/2026. Draft the recap with a concrete next step so it doesn't slip.

Tasks

Recommended Services

Regulatory Submission Services90%

Position Regulatory Submission Services against Solvance Pharma's near-term regulatory milestones.

Regulatory Intelligence70%

Single-pane monitoring across FDA, EMA and 120+ agencies.

Activity

  1. In Progress
    Jul 5, 2026 • 8:02 PM

    Reviewing our eCTD throughput benchmarks.

    Follow-up Jul 25, 2026Suren DheenLogged by Suren Dheen